US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IN8bio, Inc.

1.78

-0.0700-3.78%

Post-market: 1.780.00000.00%18:36 EST

Volume:29.57K

Turnover:54.42K

Market Cap:17.38M

PE:-0.28

High:1.90

Open:1.81

Low:1.78

Close:1.85

52wk High:9.86

52wk Low:1.17

Shares:9.76M

Float Shares:9.15M

Volume Ratio:0.70

T/O Rate:0.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-6.3610

EPS(LYR):-17.0525

ROE:-189.72%

ROA:-80.39%

PB:1.32

PE(LYR):-0.10

Loading ...

Overview Company News Filings

IN8BIO ernennt Kate Rochlin zur Präsidentin und Chief Operating Officer

Press Release: IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer

IN8BIO Showcases DeltEx Immunotherapy Results at IO360° Conference

IN8BIO präsentiert neue Ergebnisse zur Immuntherapie gegen solide Tumoren auf Fachkonferenzen

IN8bio (INAB) Receives a Buy from JonesTrading

IN8bio files to sell 14.38M shares of common stock for holders

IN8BIO Inc. unveils presentation on advancing gamma-delta T cell therapies for cancer

IN8bio: Clinical Momentum, Strengthened Cash Runway, and Unmodeled Pipeline Upside Support Buy Rating

IN8bio presents Phase I/II data from INB-200 trials

IN8bio Inc - Delttex Immunotherapy Doubles Median Progression-Free Survival to 13 Months

THOMSON REUTERS

IN8bio Inc - Delttex Treatment Shows No Severe Adverse Events or Toxicities

THOMSON REUTERS

IN8bio Gamma-Delta T Cell Therapy Nearly Doubles Progression-Free Survival in Glioblastoma Trial

IN8bio Presents Updated Phase I/II Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma

IN8BIO Announces Private Placement of Common Stock and Pre-Funded Warrants

BRIEF-In8bio Announces Pricing Of Private Placement Of Up To $40.2 Million

IN8bio Inc: Initial Proceeds Extend Cash Runway Into First Half of 2027

THOMSON REUTERS

IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager

IN8bio Presents Promising Clinical Trial Results

IN8BIO Reports Promising Survival Data for DeltEx DRI Cells in Glioblastoma Trial

IN8BIO Showcases Advances in Gamma-Delta T Cell Therapies in New Corporate Presentation

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/INAB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INAB\",,,,,undefined,":{"symbol":"INAB","market":"US","secType":"STK","nameCN":"IN8bio, Inc.","latestPrice":1.78,"timestamp":1771016400000,"preClose":1.85,"halted":0,"volume":29567,"hourTrading":{"tag":"盘后","latestPrice":1.78,"preClose":1.78,"latestTime":"18:36 EST","volume":10,"amount":18.1,"timestamp":1771025802566,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03783783783783787,"floatShares":9150700,"shares":9761425,"eps":-6.36096,"marketStatus":"Market Closed","change":-0.07,"latestTime":"02-13 16:00:00 EST","open":1.814,"high":1.9,"low":1.78,"amount":54423.826108299996,"amplitude":0.064865,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-6.36096,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"listingDate":1605157200000,"exchange":"NASDAQ","adjPreClose":1.85,"postHourTrading":{"tag":"盘后","latestPrice":1.78,"preClose":1.78,"latestTime":"18:36 EST","volume":10,"amount":18.1,"timestamp":1771025802566,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6955566457040168},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INAB\",,,,,undefined,":{"symbol":"INAB","floatShares":9150700,"roa":"-80.39%","roe":"-189.72%","lyrEps":-17.052505,"volumeRatio":0.6955566457040168,"shares":9761425,"dividePrice":0,"high":1.9,"amplitude":0.064865,"preClose":1.85,"low":1.78,"week52Low":1.17,"pbRate":"1.32","week52High":9.858,"institutionHeld":0,"latestPrice":1.78,"eps":-6.36096,"divideRate":0,"volume":29567,"delay":0,"ttmEps":-6.36096,"open":1.814,"prevYearClose":2.34,"prevWeekClose":1.99,"prevMonthClose":1.97,"prevQuarterClose":2.34,"fiveDayClose":1.99,"twentyDayClose":2.32,"sixtyDayClose":1.59},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INAB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"INAB","fiscalQuarterEnding":"2025/09","expectedEps":-1.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.85},{"market":"US","date":"2025-08-07","symbol":"INAB","fiscalQuarterEnding":"2025/06","expectedEps":-1.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-1.24},{"market":"US","date":"2025-06-06","symbol":"INAB","defaultRemindTime":1749216600000,"type":"split","dateTimestamp":1749182400000,"forFactor":30,"toFactor":1,"ratio":30},{"market":"US","date":"2025-05-07","symbol":"INAB","fiscalQuarterEnding":"2025/03","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2021-09-10","symbol":"INAB","fiscalQuarterEnding":"2021/06","expectedEps":-0.3,"name":null,"time":"","type":"earning","dateTimestamp":1631246400000,"reportTimeType":"","actualEps":1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INAB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INAB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1768453200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INAB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INAB","date":"2026-02-13","current":-0.279832,"percent":0.685413,"low":-60.555129,"twenty":-2.940606,"median":-1.482493,"eighty":-0.489933,"high":-0.259966,"avg":-3.790496,"sd":8.304852,"marketCap":18067344},"quantilePoints":[{"date":"2021-02-19","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-02-26","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-03-05","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-03-11","current":-60.555129,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":310890032},{"date":"2021-07-30","current":-20.321327,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":187545530},{"date":"2021-08-06","current":-19.792973,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":182669346},{"date":"2021-08-13","current":-19.000441,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":175355070},{"date":"2021-08-20","current":-15.667743,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":144597603},{"date":"2021-08-27","current":-14.936176,"twenty":-60.555129,"median":-60.555129,"eighty":-22.35346,"marketCap":137845964},{"date":"2021-09-03","current":-16.907344,"twenty":-60.555129,"median":-60.555129,"eighty":-20.215656,"marketCap":156037880},{"date":"2021-09-10","current":-17.727589,"twenty":-60.555129,"median":-60.555129,"eighty":-20.040893,"marketCap":166727976},{"date":"2021-09-17","current":-13.958732,"twenty":-60.555129,"median":-60.555129,"eighty":-19.085791,"marketCap":131281871},{"date":"2021-09-24","current":-15.155194,"twenty":-60.555129,"median":-60.555129,"eighty":-18.138817,"marketCap":142534602},{"date":"2021-10-01","current":-14.736432,"twenty":-60.555129,"median":-60.555129,"eighty":-17.663778,"marketCap":138596146},{"date":"2021-10-08","current":-12.881915,"twenty":-60.555129,"median":-60.555129,"eighty":-16.140999,"marketCap":121154412},{"date":"2021-10-15","current":-11.984369,"twenty":-60.555129,"median":-60.555129,"eighty":-15.651486,"marketCap":112712988},{"date":"2021-10-22","current":-13.280736,"twenty":-60.555129,"median":-60.555129,"eighty":-14.97998,"marketCap":124905322},{"date":"2021-10-29","current":-15.135253,"twenty":-60.555129,"median":-60.555129,"eighty":-14.672621,"marketCap":142347057},{"date":"2021-11-05","current":-14.955784,"twenty":-60.555129,"median":-60.555129,"eighty":-14.748397,"marketCap":140659147},{"date":"2021-11-12","current":-14.224101,"twenty":-60.555129,"median":-60.555129,"eighty":-14.60881,"marketCap":158100881},{"date":"2021-11-19","current":-11.473771,"twenty":-60.555129,"median":-22.35346,"eighty":-14.426892,"marketCap":127530960},{"date":"2021-11-26","current":-11.389405,"twenty":-60.555129,"median":-22.35346,"eighty":-13.958732,"marketCap":126593232},{"date":"2021-12-03","current":-9.448987,"twenty":-60.555129,"median":-20.321327,"eighty":-13.818503,"marketCap":105025496},{"date":"2021-12-10","current":-11.170053,"twenty":-60.555129,"median":-20.199399,"eighty":-13.58292,"marketCap":124155140},{"date":"2021-12-17","current":-10.36014,"twenty":-60.555129,"median":-20.04699,"eighty":-13.380441,"marketCap":115152955},{"date":"2021-12-23","current":-10.377013,"twenty":-60.555129,"median":-19.843776,"eighty":-13.252819,"marketCap":115340500},{"date":"2021-12-31","current":-7.407331,"twenty":-60.555129,"median":-19.000441,"eighty":-12.570834,"marketCap":82332487},{"date":"2022-01-07","current":-7.230163,"twenty":-60.555129,"median":-18.461926,"eighty":-12.206067,"marketCap":80363259},{"date":"2022-01-14","current":-6.833643,"twenty":-60.555129,"median":-17.887117,"eighty":-11.984528,"marketCap":75955939},{"date":"2022-01-21","current":-5.419838,"twenty":-60.555129,"median":-17.727589,"eighty":-11.677476,"marketCap":60241499},{"date":"2022-01-28","current":-5.061958,"twenty":-60.555129,"median":-16.898705,"eighty":-11.301664,"marketCap":56263659},{"date":"2022-02-04","current":-5.483787,"twenty":-60.555129,"median":-16.175776,"eighty":-10.967575,"marketCap":60952297},{"date":"2022-02-11","current":-7.069867,"twenty":-60.555129,"median":-15.983021,"eighty":-10.387137,"marketCap":78581577},{"date":"2022-02-18","current":-6.81677,"twenty":-60.555129,"median":-15.647422,"eighty":-10.120541,"marketCap":75768394},{"date":"2022-02-25","current":-7.322965,"twenty":-60.555129,"median":-15.411038,"eighty":-9.418616,"marketCap":81394760},{"date":"2022-03-04","current":-7.13736,"twenty":-60.555129,"median":-15.198094,"eighty":-9.287005,"marketCap":79331759},{"date":"2022-03-11","current":-5.399421,"twenty":-60.555129,"median":-15.055489,"eighty":-7.731297,"marketCap":60014569},{"date":"2022-03-18","current":-3.748845,"twenty":-60.555129,"median":-14.955784,"eighty":-7.444452,"marketCap":54931819},{"date":"2022-03-25","current":-4.288062,"twenty":-60.555129,"median":-14.796256,"eighty":-7.302717,"marketCap":62832971},{"date":"2022-04-01","current":-4.416447,"twenty":-60.555129,"median":-14.626756,"eighty":-7.171106,"marketCap":64714198},{"date":"2022-04-08","current":-5.289466,"twenty":-60.555129,"median":-14.428142,"eighty":-7.076617,"marketCap":77506540},{"date":"2022-04-14","current":-4.4687,"twenty":-60.555129,"median":-14.426579,"eighty":-6.951755,"marketCap":65479857},{"date":"2022-04-22","current":-4.64754,"twenty":-60.555129,"median":-14.038496,"eighty":-6.889324,"marketCap":68100406},{"date":"2022-04-29","current":-3.081242,"twenty":-60.555129,"median":-13.958732,"eighty":-6.820145,"marketCap":45149440},{"date":"2022-05-06","current":-3.346101,"twenty":-60.555129,"median":-13.77786,"eighty":-6.48268,"marketCap":49030411},{"date":"2022-05-13","current":-2.840843,"twenty":-60.555129,"median":-13.659616,"eighty":-6.014858,"marketCap":52370949},{"date":"2022-05-20","current":-2.237931,"twenty":-60.555129,"median":-13.521562,"eighty":-5.632272,"marketCap":41256251},{"date":"2022-05-27","current":-2.411651,"twenty":-60.555129,"median":-13.380441,"eighty":-5.517534,"marketCap":44458791},{"date":"2022-06-03","current":-2.707998,"twenty":-60.555129,"median":-13.280736,"eighty":-5.419838,"marketCap":49921948},{"date":"2022-06-10","current":-2.452527,"twenty":-60.555129,"median":-13.051414,"eighty":-5.315055,"marketCap":45212330},{"date":"2022-06-17","current":-2.3299,"twenty":-60.555129,"median":-12.582799,"eighty":-5.161081,"marketCap":42951713},{"date":"2022-06-24","current":-2.483183,"twenty":-60.555129,"median":-12.363448,"eighty":-4.711057,"marketCap":45777484},{"date":"2022-07-01","current":-2.268587,"twenty":-60.555129,"median":-12.190881,"eighty":-4.552535,"marketCap":41821405},{"date":"2022-07-08","current":-2.499738,"twenty":-60.555129,"median":-12.131058,"eighty":-4.42415,"marketCap":46082667},{"date":"2022-07-15","current":-2.217493,"twenty":-60.555129,"median":-11.984369,"eighty":-4.339416,"marketCap":40879482},{"date":"2022-07-22","current":-2.457636,"twenty":-60.555129,"median":-11.64557,"eighty":-4.254681,"marketCap":45306522},{"date":"2022-07-29","current":-2.595591,"twenty":-60.555129,"median":-11.473771,"eighty":-4.172515,"marketCap":47849716},{"date":"2022-08-05","current":-2.452527,"twenty":-60.555129,"median":-11.170053,"eighty":-3.923449,"marketCap":45212330},{"date":"2022-08-12","current":-1.544548,"twenty":-60.555129,"median":-11.035068,"eighty":-3.402872,"marketCap":34851171},{"date":"2022-08-19","current":-1.998049,"twenty":-60.555129,"median":-10.75666,"eighty":-3.158273,"marketCap":45083968},{"date":"2022-08-26","current":-2.128356,"twenty":-60.555129,"median":-10.377013,"eighty":-2.846974,"marketCap":48024227},{"date":"2022-09-02","current":-2.617009,"twenty":-60.555129,"median":-10.284211,"eighty":-2.79112,"marketCap":59050198},{"date":"2022-09-09","current":-2.682163,"twenty":-60.555129,"median":-9.879254,"eighty":-2.656101,"marketCap":60520327},{"date":"2022-09-16","current":-2.725599,"twenty":-60.555129,"median":-9.398368,"eighty":-2.67239,"marketCap":61500414},{"date":"2022-09-23","current":-2.160933,"twenty":-60.555129,"median":-9.330876,"eighty":-2.636466,"marketCap":48759292},{"date":"2022-09-30","current":-2.19351,"twenty":-60.555129,"median":-7.947273,"eighty":-2.595591,"marketCap":49494357},{"date":"2022-10-07","current":-2.258664,"twenty":-60.555129,"median":-7.736358,"eighty":-2.505541,"marketCap":50964486},{"date":"2022-10-14","current":-2.182651,"twenty":-60.555129,"median":-7.474824,"eighty":-2.483183,"marketCap":49249335},{"date":"2022-10-21","current":-1.607126,"twenty":-60.555129,"median":-7.415767,"eighty":-2.467985,"marketCap":36263192},{"date":"2022-10-28","current":-2.008908,"twenty":-60.555129,"median":-7.322965,"eighty":-2.452568,"marketCap":45328990},{"date":"2022-11-04","current":-1.954613,"twenty":-60.555129,"median":-7.225945,"eighty":-2.452527,"marketCap":44103882},{"date":"2022-11-11","current":-1.576798,"twenty":-45.274461,"median":-7.13736,"eighty":-2.40552,"marketCap":41898688},{"date":"2022-11-18","current":-1.318609,"twenty":-22.35346,"median":-7.086741,"eighty":-2.353137,"marketCap":35038084},{"date":"2022-11-25","current":-1.493809,"twenty":-22.35346,"median":-7.044557,"eighty":-2.336787,"marketCap":39693494},{"date":"2022-12-02","current":-1.954861,"twenty":-22.35346,"median":-6.951755,"eighty":-2.319682,"marketCap":51944572},{"date":"2022-12-09","current":-2.176166,"twenty":-21.947033,"median":-6.91379,"eighty":-2.291069,"marketCap":57825090},{"date":"2022-12-16","current":-1.576798,"twenty":-20.321327,"median":-6.867389,"eighty":-2.277598,"marketCap":41898688},{"date":"2022-12-23","current":-1.632125,"twenty":-20.30507,"median":-6.825207,"eighty":-2.25851,"marketCap":43368817},{"date":"2022-12-30","current":-2.130061,"twenty":-20.240042,"median":-6.79146,"eighty":-2.249935,"marketCap":56599982},{"date":"2023-01-06","current":-2.609555,"twenty":-20.207528,"median":-6.500397,"eighty":-2.249578,"marketCap":69341104},{"date":"2023-01-13","current":-2.130061,"twenty":-20.101857,"median":-6.293701,"eighty":-2.248149,"marketCap":56599982},{"date":"2023-01-20","current":-2.139282,"twenty":-20.065278,"median":-6.008422,"eighty":-2.222649,"marketCap":56845004},{"date":"2023-01-27","current":-2.102398,"twenty":-20.044957,"median":-5.763894,"eighty":-2.196076,"marketCap":55864917},{"date":"2023-02-03","current":-2.231493,"twenty":-19.951479,"median":-5.568153,"eighty":-2.194169,"marketCap":59295219},{"date":"2023-02-10","current":-1.779661,"twenty":-19.833615,"median":-5.517534,"eighty":-2.176617,"marketCap":47289163},{"date":"2023-02-17","current":-1.800593,"twenty":-19.573503,"median":-5.483787,"eighty":-2.16454,"marketCap":47845361},{"date":"2023-02-24","current":-1.346272,"twenty":-19.25649,"median":-5.405012,"eighty":-2.156798,"marketCap":35773149},{"date":"2023-03-03","current":-1.456925,"twenty":-18.976055,"median":-5.348802,"eighty":-2.139282,"marketCap":38713408},{"date":"2023-03-10","current":-1.171073,"twenty":-18.760649,"median":-5.247563,"eighty":-2.137131,"marketCap":31117739},{"date":"2023-03-17","current":-1.078862,"twenty":-18.468022,"median":-5.111519,"eighty":-2.129038,"marketCap":28667523},{"date":"2023-03-24","current":-1.134188,"twenty":-18.28513,"median":-4.724571,"eighty":-2.11729,"marketCap":30137653},{"date":"2023-03-31","current":-1.116819,"twenty":-17.994243,"median":-4.628283,"eighty":-2.093853,"marketCap":31852804},{"date":"2023-04-06","current":-1.013728,"twenty":-17.857797,"median":-4.525575,"eighty":-2.054716,"marketCap":28912545},{"date":"2023-04-14","current":-1.108228,"twenty":-17.737933,"median":-4.429286,"eighty":-2.044514,"marketCap":31607782},{"date":"2023-04-21","current":-0.9793,"twenty":-17.711636,"median":-4.39077,"eighty":-2.024631,"marketCap":27930624},{"date":"2023-04-28","current":-1.600107,"twenty":-17.499729,"median":-4.3009,"eighty":-2.010187,"marketCap":45636646},{"date":"2023-05-05","current":-2.002319,"twenty":-16.903888,"median":-4.281643,"eighty":-2.008908,"marketCap":57108152},{"date":"2023-05-12","current":-1.906138,"twenty":-16.800043,"median":-4.223869,"eighty":-2.008908,"marketCap":54364966},{"date":"2023-05-19","current":-3.134129,"twenty":-16.387118,"median":-4.172515,"eighty":-2.008908,"marketCap":93713596},{"date":"2023-05-26","current":-2.576951,"twenty":-16.167082,"median":-4.031292,"eighty":-2.009164,"marketCap":77053401},{"date":"2023-06-02","current":-3.044583,"twenty":-16.132305,"median":-3.87723,"eighty":-2.010187,"marketCap":91036064},{"date":"2023-06-09","current":-2.397858,"twenty":-16.013206,"median":-3.466397,"eighty":-2.010187,"marketCap":71698338},{"date":"2023-06-16","current":-2.109319,"twenty":-15.952836,"median":-3.338012,"eighty":-2.010187,"marketCap":63070737},{"date":"2023-06-23","current":-1.910326,"twenty":-15.724762,"median":-3.218941,"eighty":-2.008908,"marketCap":57120668},{"date":"2023-06-30","current":-1.611838,"twenty":-15.65555,"median":-3.138239,"eighty":-2.001778,"marketCap":48195563},{"date":"2023-07-07","current":-1.661586,"twenty":-15.570177,"median":-3.134129,"eighty":-1.998049,"marketCap":49683081},{"date":"2023-07-14","current":-1.691435,"twenty":-15.437001,"median":-3.034633,"eighty":-1.966279,"marketCap":50575591},{"date":"2023-07-21","current":-1.591939,"twenty":-15.343021,"median":-2.997073,"eighty":-1.948098,"marketCap":47600556},{"date":"2023-07-28","current":-1.238727,"twenty":-15.240995,"median":-2.910292,"eighty":-1.927198,"marketCap":37039183},{"date":"2023-08-04","current":-1.263601,"twenty":-15.206675,"median":-2.86549,"eighty":-1.903019,"marketCap":37782941},{"date":"2023-08-11","current":-1.144206,"twenty":-15.147218,"median":-2.826657,"eighty":-1.879294,"marketCap":34212900},{"date":"2023-08-18","current":-1.183602,"twenty":-15.103347,"median":-2.765993,"eighty":-1.844935,"marketCap":36025305},{"date":"2023-08-25","current":-1.059013,"twenty":-15.015607,"median":-2.720922,"eighty":-1.788034,"marketCap":32233167},{"date":"2023-09-01","current":-1.09016,"twenty":-14.955784,"median":-2.706296,"eighty":-1.751998,"marketCap":33181202},{"date":"2023-09-08","current":-1.005128,"twenty":-14.955784,"median":-2.665875,"eighty":-1.734645,"marketCap":30593068},{"date":"2023-09-15","current":-0.975953,"twenty":-14.951862,"median":-2.637688,"eighty":-1.702114,"marketCap":29705076},{"date":"2023-09-22","current":-1.204367,"twenty":-14.908192,"median":-2.636466,"eighty":-1.688248,"marketCap":36657328},{"date":"2023-09-29","current":-1.152455,"twenty":-14.784291,"median":-2.613282,"eighty":-1.672875,"marketCap":35077270},{"date":"2023-10-06","current":-1.017587,"twenty":-14.720479,"median":-2.595591,"eighty":-1.660148,"marketCap":30972282},{"date":"2023-10-13","current":-0.986335,"twenty":-14.644703,"median":-2.581926,"eighty":-1.631815,"marketCap":30021087},{"date":"2023-10-20","current":-0.996718,"twenty":-14.592857,"median":-2.545008,"eighty":-1.604995,"marketCap":30337099},{"date":"2023-10-27","current":-1.038248,"twenty":-14.58488,"median":-2.535787,"eighty":-1.598161,"marketCap":31601145},{"date":"2023-11-03","current":-1.038248,"twenty":-14.487647,"median":-2.512992,"eighty":-1.579913,"marketCap":31601145},{"date":"2023-11-10","current":-1.04863,"twenty":-14.428142,"median":-2.508124,"eighty":-1.53388,"marketCap":31917156},{"date":"2023-11-17","current":-0.975284,"twenty":-14.427204,"median":-2.499738,"eighty":-1.499342,"marketCap":29460407},{"date":"2023-11-24","current":-0.773116,"twenty":-14.345588,"median":-2.483183,"eighty":-1.472685,"marketCap":23353524},{"date":"2023-12-01","current":-0.879023,"twenty":-14.181765,"median":-2.475843,"eighty":-1.42357,"marketCap":26552637},{"date":"2023-12-08","current":-1.045507,"twenty":-14.054449,"median":-2.460191,"eighty":-1.396066,"marketCap":31581643},{"date":"2023-12-15","current":-2.478208,"twenty":-13.958732,"median":-2.457636,"eighty":-1.392378,"marketCap":74859244},{"date":"2023-12-22","current":-1.846609,"twenty":-13.958732,"median":-2.452578,"eighty":-1.396066,"marketCap":55780526},{"date":"2023-12-29","current":-2.032702,"twenty":-13.958732,"median":-2.452527,"eighty":-1.401599,"marketCap":61401819},{"date":"2024-01-05","current":-1.989757,"twenty":-13.925599,"median":-2.452527,"eighty":-1.402377,"marketCap":60104598},{"date":"2024-01-12","current":-2.204479,"twenty":-13.852506,"median":-2.432089,"eighty":-1.40765,"marketCap":66590705},{"date":"2024-01-19","current":-2.063553,"twenty":-13.785989,"median":-2.419201,"eighty":-1.41082,"marketCap":62333748},{"date":"2024-01-26","current":-1.86293,"twenty":-13.736241,"median":-2.404062,"eighty":-1.42357,"marketCap":56273522},{"date":"2024-02-02","current":-1.719628,"twenty":-13.704713,"median":-2.380995,"eighty":-1.448386,"marketCap":51944790},{"date":"2024-02-09","current":-1.748288,"twenty":-13.628938,"median":-2.367158,"eighty":-1.456925,"marketCap":52810536},{"date":"2024-02-16","current":-1.576325,"twenty":-13.58292,"median":-2.350965,"eighty":-1.460613,"marketCap":47616057},{"date":"2024-02-23","current":-1.447353,"twenty":-13.558377,"median":-2.345229,"eighty":-1.458769,"marketCap":43720198},{"date":"2024-03-01","current":-1.590655,"twenty":-13.444252,"median":-2.3299,"eighty":-1.456925,"marketCap":48048930},{"date":"2024-03-08","current":-1.748288,"twenty":-13.380441,"median":-2.319682,"eighty":-1.458769,"marketCap":52810536},{"date":"2024-03-15","current":-1.662307,"twenty":-13.376453,"median":-2.304353,"eighty":-1.46812,"marketCap":50213297},{"date":"2024-03-22","current":-1.803218,"twenty":-13.344547,"median":-2.289025,"eighty":-1.47731,"marketCap":54109156},{"date":"2024-03-28","current":-1.745515,"twenty":-13.280736,"median":-2.278806,"eighty":-1.482493,"marketCap":52377663},{"date":"2024-04-05","current":-1.615683,"twenty":-13.260795,"median":-2.273092,"eighty":-1.493809,"marketCap":48481804},{"date":"2024-04-12","current":-1.65896,"twenty":-13.220913,"median":-2.258664,"eighty":-1.493809,"marketCap":49780423},{"date":"2024-04-19","current":-1.514703,"twenty":-12.881915,"median":-2.256631,"eighty":-1.482493,"marketCap":45451691},{"date":"2024-04-26","current":-1.500277,"twenty":-12.662564,"median":-2.248149,"eighty":-1.482493,"marketCap":45018818},{"date":"2024-05-03","current":-1.496325,"twenty":-12.582799,"median":-2.24304,"eighty":-1.482493,"marketCap":44900232},{"date":"2024-05-10","current":-1.432162,"twenty":-12.522976,"median":-2.231493,"eighty":-1.471426,"marketCap":44460034},{"date":"2024-05-17","current":-1.446342,"twenty":-12.363448,"median":-2.22179,"eighty":-1.466146,"marketCap":44900232},{"date":"2024-05-24","current":-1.47456,"twenty":-12.249186,"median":-2.21305,"eighty":-1.460522,"marketCap":45776227},{"date":"2024-05-31","current":-1.463976,"twenty":-12.22279,"median":-2.204479,"eighty":-1.456925,"marketCap":45447667},{"date":"2024-06-07","current":-1.606109,"twenty":-12.175695,"median":-2.195832,"eighty":-1.459803,"marketCap":49860062},{"date":"2024-06-14","current":-2.387844,"twenty":-12.164651,"median":-2.194059,"eighty":-1.462594,"marketCap":74128234},{"date":"2024-06-21","current":-1.307913,"twenty":-12.137654,"median":-2.185365,"eighty":-1.456925,"marketCap":40602857},{"date":"2024-06-28","current":-1.278207,"twenty":-12.111271,"median":-2.180423,"eighty":-1.456032,"marketCap":39680667},{"date":"2024-07-05","current":-1.134937,"twenty":-12.029972,"median":-2.177406,"eighty":-1.446342,"marketCap":35232973},{"date":"2024-07-12","current":-1.194064,"twenty":-11.984449,"median":-2.176166,"eighty":-1.442646,"marketCap":37068529},{"date":"2024-07-15","current":-1.247649,"twenty":-11.984409,"median":-2.173979,"eighty":-1.442545,"marketCap":38732002},{"date":"2024-08-02","current":-1.208135,"twenty":-11.984369,"median":-2.171792,"eighty":-1.44243,"marketCap":37505356},{"date":"2024-08-09","current":-0.972336,"twenty":-11.964627,"median":-2.163939,"eighty":-1.432162,"marketCap":30185193},{"date":"2024-08-16","current":-0.882654,"twenty":-11.805099,"median":-2.157724,"eighty":-1.410954,"marketCap":28207850},{"date":"2024-08-23","current":-0.761433,"twenty":-11.486042,"median":-2.153127,"eighty":-1.401599,"marketCap":24333891},{"date":"2024-08-30","current":-0.760116,"twenty":-11.473771,"median":-2.145961,"eighty":-1.383157,"marketCap":24291783},{"date":"2024-09-06","current":-0.49469,"twenty":-11.473771,"median":-2.139282,"eighty":-1.363657,"marketCap":15809309},{"date":"2024-09-13","current":-0.440961,"twenty":-11.406278,"median":-2.139215,"eighty":-1.340739,"marketCap":14092228},{"date":"2024-09-20","current":-0.470095,"twenty":-11.213923,"median":-2.135742,"eighty":-1.289457,"marketCap":15023289},{"date":"2024-09-27","current":-0.417244,"twenty":-11.170053,"median":-2.130061,"eighty":-1.276954,"marketCap":13334280},{"date":"2024-10-04","current":-0.3865,"twenty":-11.143056,"median":-2.126474,"eighty":-1.252451,"marketCap":12351754},{"date":"2024-10-11","current":-0.336577,"twenty":-11.055316,"median":-2.117497,"eighty":-1.235515,"marketCap":10756319},{"date":"2024-10-18","current":-0.33687,"twenty":-10.900082,"median":-2.109319,"eighty":-1.21758,"marketCap":10765676},{"date":"2024-10-25","current":-0.468631,"twenty":-10.812342,"median":-2.095323,"eighty":-1.203755,"marketCap":14976502},{"date":"2024-10-31","current":-0.39543,"twenty":-10.748223,"median":-2.092695,"eighty":-1.194032,"marketCap":12637154},{"date":"2024-11-08","current":-0.484003,"twenty":-10.522122,"median":-2.089364,"eighty":-1.182279,"marketCap":15467765},{"date":"2024-11-15","current":-0.493189,"twenty":-10.383762,"median":-2.069928,"eighty":-1.172361,"marketCap":15720414},{"date":"2024-11-22","current":-0.727675,"twenty":-10.366889,"median":-2.063526,"eighty":-1.163203,"marketCap":23194640},{"date":"2024-11-29","current":-0.692883,"twenty":-10.333143,"median":-2.052343,"eighty":-1.153748,"marketCap":22085647},{"date":"2024-12-06","current":-0.682195,"twenty":-10.285898,"median":-2.047072,"eighty":-1.146883,"marketCap":21744975},{"date":"2024-12-13","current":-0.66082,"twenty":-10.120541,"median":-2.043874,"eighty":-1.13907,"marketCap":21063633},{"date":"2024-12-20","current":-0.546666,"twenty":-9.880941,"median":-2.034998,"eighty":-1.134188,"marketCap":17424974},{"date":"2024-12-27","current":-0.578502,"twenty":-9.786451,"median":-2.03022,"eighty":-1.134038,"marketCap":18439739},{"date":"2025-01-03","current":-0.63717,"twenty":-9.448987,"median":-2.021551,"eighty":-1.122855,"marketCap":20309807},{"date":"2025-01-10","current":-0.710847,"twenty":-9.408492,"median":-2.010187,"eighty":-1.116819,"marketCap":22658264},{"date":"2025-01-17","current":-0.674464,"twenty":-9.371371,"median":-2.008908,"eighty":-1.107887,"marketCap":21498532},{"date":"2025-01-24","current":-0.652179,"twenty":-9.364622,"median":-2.004072,"eighty":-1.101073,"marketCap":20788196},{"date":"2025-01-31","current":-0.563721,"twenty":-9.324126,"median":-2.001642,"eighty":-1.097961,"marketCap":17968598},{"date":"2025-02-07","current":-0.629894,"twenty":-9.287005,"median":-1.998049,"eighty":-1.084711,"marketCap":20077861},{"date":"2025-02-14","current":-0.734724,"twenty":-8.480466,"median":-1.989757,"eighty":-1.079412,"marketCap":23419339},{"date":"2025-02-21","current":-0.65036,"twenty":-7.873031,"median":-1.984857,"eighty":-1.069395,"marketCap":20730210},{"date":"2025-02-28","current":-0.576228,"twenty":-7.761668,"median":-1.963783,"eighty":-1.052376,"marketCap":18367256},{"date":"2025-03-07","current":-0.58828,"twenty":-7.74142,"median":-1.954613,"eighty":-1.046541,"marketCap":18751417},{"date":"2025-03-14","current":-0.514603,"twenty":-7.684052,"median":-1.94723,"eighty":-1.038248,"marketCap":16402960},{"date":"2025-03-21","current":-0.621782,"twenty":-7.576063,"median":-1.937378,"eighty":-1.029162,"marketCap":18925165},{"date":"2025-03-28","current":-0.555572,"twenty":-7.474824,"median":-1.932498,"eighty":-1.018376,"marketCap":16909948},{"date":"2025-04-04","current":-0.430361,"twenty":-7.454576,"median":-1.923725,"eighty":-1.015188,"marketCap":13098912},{"date":"2025-04-11","current":-0.392718,"twenty":-7.417455,"median":-1.910326,"eighty":-1.00529,"marketCap":11953164},{"date":"2025-04-17","current":-0.42075,"twenty":-7.400582,"median":-1.906138,"eighty":-0.992946,"marketCap":12806381},{"date":"2025-04-25","current":-0.493901,"twenty":-7.363461,"median":-1.902764,"eighty":-0.983856,"marketCap":15032871},{"date":"2025-05-02","current":-0.453588,"twenty":-7.316216,"median":-1.899535,"eighty":-0.976534,"marketCap":13805863},{"date":"2025-05-09","current":-0.497478,"twenty":-7.277408,"median":-1.883407,"eighty":-0.972926,"marketCap":13643346},{"date":"2025-05-16","current":-0.438552,"twenty":-7.228476,"median":-1.871872,"eighty":-0.963991,"marketCap":12027282},{"date":"2025-05-23","current":-0.439545,"twenty":-7.221726,"median":-1.86293,"eighty":-0.937651,"marketCap":12054514},{"date":"2025-05-30","current":-0.507727,"twenty":-7.221726,"median":-1.86244,"eighty":-0.918094,"marketCap":13924416},{"date":"2025-06-06","current":-0.452491,"twenty":-7.13736,"median":-1.85343,"eighty":-0.881988,"marketCap":12409571},{"date":"2025-06-13","current":-0.298898,"twenty":-7.120487,"median":-1.846259,"eighty":-0.836826,"marketCap":8197267},{"date":"2025-06-20","current":-0.267501,"twenty":-7.09349,"median":-1.844209,"eighty":-0.789983,"marketCap":7336209},{"date":"2025-06-27","current":-0.271268,"twenty":-7.086741,"median":-1.819939,"eighty":-0.773116,"marketCap":7439536},{"date":"2025-07-03","current":-0.27378,"twenty":-7.076617,"median":-1.803218,"eighty":-0.769837,"marketCap":7508421},{"date":"2025-07-11","current":-0.287595,"twenty":-7.039496,"median":-1.795936,"eighty":-0.758828,"marketCap":7887286},{"date":"2025-07-18","current":-0.276292,"twenty":-6.978752,"median":-1.788792,"eighty":-0.734997,"marketCap":7577306},{"date":"2025-07-25","current":-0.302665,"twenty":-6.951755,"median":-1.776194,"eighty":-0.730523,"marketCap":8300594},{"date":"2025-08-01","current":-0.267501,"twenty":-6.941631,"median":-1.775035,"eighty":-0.721671,"marketCap":7336209},{"date":"2025-08-08","current":-0.270013,"twenty":-6.924758,"median":-1.766314,"eighty":-0.708482,"marketCap":7405094},{"date":"2025-08-15","current":-0.456062,"twenty":-6.912947,"median":-1.751998,"eighty":-0.69467,"marketCap":10895320},{"date":"2025-08-22","current":-0.425658,"twenty":-6.894386,"median":-1.74829,"eighty":-0.690108,"marketCap":10168966},{"date":"2025-08-29","current":-0.429458,"twenty":-6.874138,"median":-1.748288,"eighty":-0.678245,"marketCap":10259760},{"date":"2025-09-05","current":-0.414256,"twenty":-6.853891,"median":-1.745515,"eighty":-0.665277,"marketCap":9896583},{"date":"2025-09-12","current":-0.397154,"twenty":-6.833643,"median":-1.732763,"eighty":-0.657272,"marketCap":9488008},{"date":"2025-09-19","current":-0.391453,"twenty":-6.826894,"median":-1.731089,"eighty":-0.65036,"marketCap":9351817},{"date":"2025-09-26","current":-0.397154,"twenty":-6.81677,"median":-1.722809,"eighty":-0.632804,"marketCap":9488008},{"date":"2025-10-03","current":-0.435159,"twenty":-6.796522,"median":-1.719628,"eighty":-0.622116,"marketCap":10395951},{"date":"2025-10-10","current":-0.44276,"twenty":-6.67166,"median":-1.703635,"eighty":-0.615477,"marketCap":10577540},{"date":"2025-10-17","current":-0.400954,"twenty":-6.506303,"median":-1.696672,"eighty":-0.61102,"marketCap":9578802},{"date":"2025-10-24","current":-0.399054,"twenty":-6.4135,"median":-1.691412,"eighty":-0.608649,"marketCap":9533405},{"date":"2025-10-31","current":-0.378151,"twenty":-6.313949,"median":-1.683139,"eighty":-0.604743,"marketCap":9034036},{"date":"2025-11-07","current":-0.315443,"twenty":-6.192462,"median":-1.674883,"eighty":-0.589735,"marketCap":7535930},{"date":"2025-11-14","current":-0.367916,"twenty":-5.748368,"median":-1.661586,"eighty":-0.581385,"marketCap":7600409},{"date":"2025-11-21","current":-0.356699,"twenty":-5.517534,"median":-1.651636,"eighty":-0.574045,"marketCap":7368689},{"date":"2025-11-28","current":-0.444191,"twenty":-5.410942,"median":-1.632125,"eighty":-0.562811,"marketCap":9176104},{"date":"2025-12-05","current":-0.408297,"twenty":-5.264324,"median":-1.607126,"eighty":-0.54994,"marketCap":8434600},{"date":"2025-12-12","current":-0.388107,"twenty":-4.859526,"median":-1.601257,"eighty":-0.523633,"marketCap":8017505},{"date":"2025-12-19","current":-0.309588,"twenty":-4.516588,"median":-1.590655,"eighty":-0.504443,"marketCap":6395466},{"date":"2025-12-26","current":-0.448678,"twenty":-4.408744,"median":-1.586832,"eighty":-0.493616,"marketCap":9268792},{"date":"2026-01-02","current":-0.524953,"twenty":-4.3009,"median":-1.576798,"eighty":-0.492778,"marketCap":10844486},{"date":"2026-01-09","current":-0.538414,"twenty":-4.20076,"median":-1.549256,"eighty":-0.492778,"marketCap":11122550},{"date":"2026-01-16","current":-0.520467,"twenty":-3.985073,"median":-1.525665,"eighty":-0.489933,"marketCap":10751798},{"date":"2026-01-23","current":-1.172427,"twenty":-3.461262,"median":-1.514703,"eighty":-0.489933,"marketCap":24220007},{"date":"2026-01-30","current":-0.945506,"twenty":-3.213353,"median":-1.500277,"eighty":-0.489933,"marketCap":19532264},{"date":"2026-02-06","current":-0.898231,"twenty":-3.059247,"median":-1.493809,"eighty":-0.489933,"marketCap":18555650},{"date":"2026-02-13","current":-0.874593,"twenty":-2.940606,"median":-1.482493,"eighty":-0.489933,"marketCap":18067344}],"updateTime":1771147878253},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INAB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610584666","title":"IN8BIO ernennt Kate Rochlin zur Präsidentin und Chief Operating Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2610584666","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610584666?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:00","pubTimestamp":1770642055,"startTime":"0","endTime":"0","summary":"IN8BIO Inc. hat die Befrderung von Kate Rochlin, Ph.D., zur Prsidentin und Chief Operating Officer bekannt gegeben. Rochlin war zuvor als Chief Operating Officer ttig und übernimmt ab sofort die erweiterte Führungsrolle.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IN8BIO Inc. published the original content used to generate this news brief via GlobeNewswire  on February 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL7YjBb3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU2095319765.USD","LU0314104364.USD","LU2210150020.SGD","IE00B64PRP62.GBP","SG9999014013.SGD","BK4139","SG9999014021.USD","SG9999014039.USD","BK4585","LU2210149790.SGD","BK4112","IE00BGHQF748.EUR","BK4539","SG9999014005.SGD","BK4588","INAB","IE00BKPKM429.USD","NDAQ"],"gpt_icon":0},{"id":"2610582656","title":"Press Release: IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2610582656","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610582656?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:00","pubTimestamp":1770642000,"startTime":"0","endTime":"0","summary":"NEW YORK, Feb. 09, 2026  -- IN8bio , a clinical-stage biopharmaceutical company developing innovative gamma-delta  T cell therapies and T cell engagers for cancer and autoimmune diseases, today announced the promotion of Kate Rochlin, Ph.D., to President and Chief Operating Officer, effective immediately.Dr. Rochlin has served as IN8bio's Chief Operating Officer since December 2021, following her tenure as Vice President and Associate Vice President of Operations and Innovation beginning in August 2020. In her expanded role, she will continue to oversee company operations as IN8bio advances its clinical and preclinical pipeline and prepares for its next phase of growth.\"I'm honored to take on this expanded role and broader leadership responsibilities at such an important time for IN8bio,\" said Dr. Rochlin. \"With encouraging clinical data emerging from our <GAMMA> T cell therapy programs and novel gamma-delta T cell engager technology, we are well positioned to build on this momentum. I","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB"],"gpt_icon":0},{"id":"2608879393","title":"IN8BIO Showcases DeltEx Immunotherapy Results at IO360° Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2608879393","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608879393?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:01","pubTimestamp":1770123665,"startTime":"0","endTime":"0","summary":"IN8BIO Inc., a clinical-stage biopharmaceutical company developing gamma-delta T cell therapies, will participate in the Noble Emerging Growth Virtual Equity Conference on February 5, 2026, at 3:00 p.m. ET. Additionally, the company will present at the IO360° Conference on February 12, 2026, from 1:20 p.m. to 1:40 p.m. ET, where CEO William Ho will discuss IN8bio's DeltEx Drug Resistant Immunotherapy approach and results from a Phase 1/2 study in newly diagnosed glioblastoma multiforme . Further details and webcast information will be available on the company's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IN8BIO Inc. published the original content used to generate this news brief via GlobeNewswire  on February 03, 2026, and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDLRCSZC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00BGHQF748.EUR","BK4539","LU2210149790.SGD","NDAQ","BK4588","SG9999014005.SGD","BK4112","IE00B64PRP62.GBP","LU2095319765.USD","IE00B3QW5Z07.USD","SG9999014039.USD","BK4585","SG9999014021.USD","IE00BKPKM429.USD","INAB","LU2210150020.SGD","BK4139","SG9999014013.SGD"],"gpt_icon":0},{"id":"2608879310","title":"IN8BIO präsentiert neue Ergebnisse zur Immuntherapie gegen solide Tumoren auf Fachkonferenzen","url":"https://stock-news.laohu8.com/highlight/detail?id=2608879310","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608879310?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:01","pubTimestamp":1770123664,"startTime":"0","endTime":"0","summary":"IN8BIO Inc. wird am 5. Februar 2026 am Noble Emerging Growth Virtual Equity Conference teilnehmen. Zudem prsentiert das Unternehmen am 12. Februar 2026 auf der IO360° Conference neueste Ergebnisse zur DeltEx Drug Resistant Immunotherapy  bei soliden Tumoren und aus einer Phase-1/2-Studie bei neu diagnostiziertem Glioblastoma multiforme .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IN8BIO Inc. published the original content used to generate this news brief via GlobeNewswire  on February 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDLJCmd3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SG9999014013.SGD","BK4112","LU0314104364.USD","INAB","SG9999014005.SGD","SG9999014039.USD","NDAQ","BK4539","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU2095319765.USD","LU2210149790.SGD","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4585","IE00BGHQF748.EUR","SG9999014021.USD","BK4588"],"gpt_icon":0},{"id":"2605147020","title":"IN8bio (INAB) Receives a Buy from JonesTrading","url":"https://stock-news.laohu8.com/highlight/detail?id=2605147020","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605147020?lang=en_us&edition=fundamental","pubTime":"2026-01-23 20:51","pubTimestamp":1769172679,"startTime":"0","endTime":"0","summary":"In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on IN8bio, with a price target of $5.00. Roy covers the Healthcare...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/in8bio-inab-receives-a-buy-from-jonestrading-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/in8bio-inab-receives-a-buy-from-jonestrading-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","LABU","INAB","BK4588","XBI","BK4139","BK4539","XLV"],"gpt_icon":0},{"id":"2605313142","title":"IN8bio files to sell 14.38M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2605313142","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605313142?lang=en_us&edition=fundamental","pubTime":"2026-01-21 06:00","pubTimestamp":1768946429,"startTime":"0","endTime":"0","summary":"16:57 EST IN8bio (INAB) files to sell 14.38M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, mark...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/in8bio-files-to-sell-14-38m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/in8bio-files-to-sell-14-38m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2604914970","title":"IN8BIO Inc. unveils presentation on advancing gamma-delta T cell therapies for cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2604914970","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604914970?lang=en_us&edition=fundamental","pubTime":"2026-01-17 06:31","pubTimestamp":1768602697,"startTime":"0","endTime":"0","summary":"IN8BIO Inc. has released a corporate presentation detailing advances in its pipeline focused on gamma-delta (γδ) T cell therapies. The update highlights ongoing clinical and preclinical programs, including the DeltEx platform for acute myeloid leukemia  and glioblastoma , with ongoing patient dosing and upcoming clinical updates projected for late 2026. The presentation also outlines research into non-signaling CAR-T cells, induced pluripotent stem cell -derived T cells, and T cell engagers for potential applications in oncology and autoimmune diseases. Additional data on completed trials and plans for regulatory engagement with the FDA are provided. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investm","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nNDL3nwRVY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2603611902","title":"IN8bio: Clinical Momentum, Strengthened Cash Runway, and Unmodeled Pipeline Upside Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2603611902","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603611902?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:56","pubTimestamp":1768398968,"startTime":"0","endTime":"0","summary":"In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on IN8bio, with a price target of $6.00. Swayampaku...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/in8bio-clinical-momentum-strengthened-cash-runway-and-unmodeled-pipeline-upside-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/in8bio-clinical-momentum-strengthened-cash-runway-and-unmodeled-pipeline-upside-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INAB"],"gpt_icon":0},{"id":"2602752548","title":"IN8bio presents Phase I/II data from INB-200 trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2602752548","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602752548?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:35","pubTimestamp":1768224956,"startTime":"0","endTime":"0","summary":"IN8bio (INAB) reported updated clinical data from its INB-200 Phase 1 and INB-400 Phase 2 trials in newly diagnosed glioblastoma. The prior results...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/in8bio-presents-phase-i-ii-data-from-inb-200-trials-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/in8bio-presents-phase-i-ii-data-from-inb-200-trials-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","INAB","INB"],"gpt_icon":0},{"id":"2602510263","title":"IN8bio Inc - Delttex Immunotherapy Doubles Median Progression-Free Survival to 13 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510263","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510263?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:15","pubTimestamp":1768223745,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD0DB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2602251025","title":"IN8bio Inc - Delttex Treatment Shows No Severe Adverse Events or Toxicities","url":"https://stock-news.laohu8.com/highlight/detail?id=2602251025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602251025?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:15","pubTimestamp":1768223745,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD0DB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2602510848","title":"IN8bio Gamma-Delta T Cell Therapy Nearly Doubles Progression-Free Survival in Glioblastoma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510848","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510848?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:01","pubTimestamp":1768222878,"startTime":"0","endTime":"0","summary":"IN8bio, Inc. has announced updated clinical data from its INB-200 Phase 1 and INB-400 Phase 2 trials evaluating DeltEx Drug-Resistant Immunotherapy  gamma-delta (γδ) T cells in newly diagnosed glioblastoma . The results were presented at the 2025 Society for Neuro-Oncology  Annual Meeting. The data showed that repeat-doses of DeltEx DRI γδ T cells nearly doubled median progression-free survival  to 13.0 months compared to 6.6 months in a standard-of-care  control cohort. Median overall survival  was reported at 17.2+ months as of December 31, 2025, compared to 13.2 months for SOC. The treatment demonstrated a favorable safety profile, with no treatment-related severe adverse events or dose limiting toxicities observed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL6bfg4T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2095319765.USD","NDAQ","SG9999014039.USD","LU2210150020.SGD","BK4588","BK4139","LU2210149790.SGD","SG9999014021.USD","BK4112","IE00B64PRP62.GBP","SG9999014013.SGD","INAB","BK4539","BK4585","IE00BKPKM429.USD","SG9999014005.SGD"],"gpt_icon":0},{"id":"2602841548","title":"IN8bio Presents Updated Phase I/II Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2602841548","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602841548?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222800,"startTime":"0","endTime":"0","summary":"Repeat-doses of DeltEx Drug-Resistant Immunotherapy gamma-delta (γδ) T cells (DRI) nearly doubled median progression-free survival (mPFS) to 13.0 months compared to only 6.6 months (+97%) in a control","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/12/3216805/0/en/IN8bio-Presents-Updated-Phase-I-II-Data-Demonstrating-Meaningful-and-Durable-Survival-Improvements-in-Newly-Diagnosed-Glioblastoma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB"],"gpt_icon":0},{"id":"2592118166","title":"IN8BIO Announces Private Placement of Common Stock and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2592118166","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592118166?lang=en_us&edition=fundamental","pubTime":"2025-12-20 06:23","pubTimestamp":1766182991,"startTime":"0","endTime":"0","summary":"IN8BIO Inc. has announced that it has entered into a Securities Purchase Agreement with certain investors for a private placement of its common stock and pre-funded warrants. The transaction, expected to close on or about December 22, 2025, will take place in up to two closings. The private placement is exempt from registration under Section 4 of the Securities Act, as all investors have represented they are accredited investors or qualified institutional buyers. The proceeds from the sale will support the company's ongoing operations and strategic initiatives.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IN8BIO Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL1PJrHr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2592607891","title":"BRIEF-In8bio Announces Pricing Of Private Placement Of Up To $40.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2592607891","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592607891?lang=en_us&edition=fundamental","pubTime":"2025-12-19 22:23","pubTimestamp":1766154182,"startTime":"0","endTime":"0","summary":"BRIEF-In8bio Announces Pricing Of Private Placement Of Up To $40.2 Million Dec 19 (Reuters) - IN8bio Inc INAB.O:IN8BIO ANNOUNCES PRICING OF PRIVATE PLACEMENT OF UP TO $40.2 MILLION TO ADVANCE NOVEL GA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XP0MR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2592616285","title":"IN8bio Inc: Initial Proceeds Extend Cash Runway Into First Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2592616285","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592616285?lang=en_us&edition=fundamental","pubTime":"2025-12-19 21:00","pubTimestamp":1766149216,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XP0MR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2592616223","title":"IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager","url":"https://stock-news.laohu8.com/highlight/detail?id=2592616223","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592616223?lang=en_us&edition=fundamental","pubTime":"2025-12-19 21:00","pubTimestamp":1766149200,"startTime":"0","endTime":"0","summary":"$20.1 million upfront with a milestone-driven additional $20.1 million to advance INB-619, IN8bio’s novel gamma-delta (“γδ”) T cell engager through an Investigational New Drug (“IND”) application Fina","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/19/3208456/0/en/IN8bio-Announces-Pricing-of-Private-Placement-of-up-to-40-2-Million-to-Advance-Novel-Gamma-Delta-T-Cell-Engager.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2586149188","title":"IN8bio Presents Promising Clinical Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2586149188","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586149188?lang=en_us&edition=fundamental","pubTime":"2025-11-25 01:04","pubTimestamp":1764003888,"startTime":"0","endTime":"0","summary":"IN8bio ( ($INAB) ) has issued an announcement. IN8bio, Inc. presented data from its Phase 1 and Phase 2 clinical trials of INB-200 and INB-400 at t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/in8bio-presents-promising-clinical-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/in8bio-presents-promising-clinical-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2586496697","title":"IN8BIO Reports Promising Survival Data for DeltEx DRI Cells in Glioblastoma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2586496697","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586496697?lang=en_us&edition=fundamental","pubTime":"2025-11-25 00:17","pubTimestamp":1764001031,"startTime":"0","endTime":"0","summary":"IN8BIO Inc. has announced new clinical data from its investigator-sponsored Phase 1 trial of INB-200 and Company-sponsored Phase 2 trial of INB-400 for the treatment of newly diagnosed glioblastoma. The results were presented in poster and oral sessions at the 2025 Society for Neuro-Oncology  Annual Meeting on November 21 and 22, 2025. Across both trials, 17 patients were treated with the Company's DeltEx DRI gamma-delta T cells, with 14 patients receiving repeated doses. These patients achieved a median progression-free survival of 13.0 months, compared to 6.6 months for 10 patients who received only the standard-of-care Stupp protocol. Median overall survival for patients treated with repeated DeltEx DRI doses has not yet been reached and was reported at 16.4+ months as of October 31, 2025, while the standard-of-care group had a median overall survival of 11.0 months.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL2dt6fH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2585462068","title":"IN8BIO Showcases Advances in Gamma-Delta T Cell Therapies in New Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2585462068","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585462068?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:19","pubTimestamp":1763990363,"startTime":"0","endTime":"0","summary":"IN8BIO Inc. has released a corporate presentation highlighting recent developments across its pipeline of gamma-delta T cell therapies. The company provided updates on its DeltEx platform, with clinical milestones anticipated for programs in acute myeloid leukemia  and glioblastoma . For AML, IN8BIO plans to complete enrollment and dosing for additional patients in an expansion cohort, with ongoing clinical updates expected in 2026. In GBM, the company aims to report long-term overall survival data and Phase 2 trial results at upcoming scientific meetings. Efforts in autoimmune indications remain on hold, with potential advancement to IND-enabling studies in 2026. Additional details regarding program prioritization are available in the company's recent SEC filings. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely informat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL1wB41y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","INAB"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}]}}